Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival
Georgeson, P.; Steinfelder, R. S.; Harrison, T. A.; Pope, B. J.; Zaidi, S. H.; Qu, C.; Lin, Y.; Joo, J. E.; Mahmood, K.; Clendenning, M.; Walker, R.; Aglago, E. K.; Berndt, S. I.; Brenner, H.; Campbell, P. T.; Cao, Y.; Chan, A. T.; Chang-Claude, J.; Dimou, N.; Doheny, K. F.; Drew, D. A.; Figueiredo, J. C.; French, A. J.; Gallinger, S.; Giannakis, M.; Giles, G. G.; Goode, E. L.; Gruber, S. B.; Gsur, A.; Gunter, M. J.; Harlid, S.; Hoffmeister, M.; Hsu, L.; Huang, W.-Y.; Huyghe, J. R.; Manson, J. E.; Moreno, V.; Murphy, N.; Nassir, R.; Newton, C. C.; Nowak, J. A.; Obon-Santacana, M.; Ogino, S.; P
Show abstract
Background and AimsThe microbiome has long been suspected of a role in colorectal cancer (CRC) tumorigenesis. The mutational signature SBS88 mechanistically links CRC development with the strain of Escherichia coli harboring the pks island that produces the genotoxin colibactin, but the genomic, pathological and survival characteristics associated with SBS88-positive tumors are unknown. MethodsSBS88-positive CRCs were identified from targeted sequencing data from 5,292 CRCs from 17 studies and tested for their association with clinico-pathological features, oncogenic pathways, genomic characteristics and survival. ResultsIn total, 7.5% (398/5,292) of the CRCs were SBS88-positive, of which 98.7% (392/398) were microsatellite stable/microsatellite instability low (MSS/MSI-L), compared with 80% (3916/4894) of SBS88 negative tumors (p=1.5x10-28). Analysis of MSS/MSI-L CRCs demonstrated that SBS88 positive CRCs were associated with the distal colon (OR=1.84, 95% CI=1.40-2.42, p=1x10-5) and rectum (OR=1.90, 95% CI=1.44-2.51, p=6x10-6) tumor sites compared with the proximal colon. The top seven recurrent somatic mutations associated with SBS88-positive CRCs demonstrated mutational contexts associated with colibactin-induced DNA damage, the strongest of which was the APC:c.835-8A>G mutation (OR=65.5, 95%CI=39.0-110.0, p=3x10-80). Large copy number alterations (CNAs) including CNA loss on 14q and gains on 13q, 16q and 20p were significantly enriched in SBS88- positive CRCs. SBS88-positive CRCs were associated with better CRC-specific survival (p=0.007; hazard ratio of 0.69, 95% CI=0.52-0.90) when stratified by age, sex, study, and by stage. ConclusionSBS88-positivity, a biomarker of colibactin-induced DNA damage, can identify a novel subtype of CRC characterized by recurrent somatic mutations, copy number alterations and better survival. These findings provide new insights for treatment and prevention strategies for this subtype of CRC.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- APC Mutation marks an aggressive subtype of BRAF mutant colorectal cancers 97%
- Deep sequencing of early T stage colorectal cancers reveals disruption of homologous recombination repair in microsatellite stable tumours with high mutational burdens 95%
- DNA mismatch repair gene variant classification: evaluating the utility of somatic mutations and mismatch repair deficient colonic crypts and endometrial glands 94%
Similar papers in this journal
- A new colorectal cancer risk prediction model incorporating family history, personal and environmental factors 94%
- The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Stomach Malignancies 93%
- Germline predisposition to oncogenic alkylating damage in colorectal cancer 92%
Similar papers in this journal
- Molecular pathways in post-colonoscopy versus detected colorectal cancers: results from a nested case-control study 96%
- Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling 91%
- Non-B DNA-Informed Mutation Burden as a Marker of Treatment Response and Outcome in Cancer 91%
Similar papers in this journal
- Molecular subtyping improves prognostication of Stage 2 colorectal cancer 95%
- Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients 94%
- An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types 92%
Similar papers in this journal
- Molecular Drivers of Tumor Progression in Microsatellite Stable APC Mutation-Negative Colorectal Cancers 97%
- The transition from primary colorectal cancer to isolated peritoneal malignancy is associated with a hypermutant, hypermethylated state 93%
- The most common RNF43 mutant G659Vfs41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.